Use and outcomes of antifibrinolytic therapy in patients undergoing cardiothoracic surgery at 20 academic medical centers in the United States

P and T

Volumn 33, Issue 2, 2008, Pages 98-106

  Matuszewski, Karl ^a   Schoenhaus, Robert ^b   Bonk, Mary Ellen ^a   Lane, James ^c,d   Oinonen, Michael ^a  

^a University HealthSystem Consortium ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCSD MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Antifibrinolytic therapy; Aprotinin; Database review; Drug safety

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANEXAMIC ACID;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; FEMALE; HEART SURGERY; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; THORAX SURGERY; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 40949126537     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl Med J 2007;356(22):2301-2311.
2. Armstrong D. Serious risks are found in heart drug. The New York Times, January 26, 2006.
3. Barclay L. Aprotinin use may increase risk for end organ damage in cardiac surgery. Medscape Medical News. Available at: www.medscape.com/ viewarticle/522313. Accessed February 14, 2006.
4. Drazen JM. Research replication (Editorial). N Engl J Med 2006;355(21):2252-2253.
5. Grady D. Doctors urge ending use of heart surgery drug. The New York Times, January 26, 2006.
6. Kristeller JL, Stahl RE, Roslund BP, Roke-Thomas M. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion. Pharmacotherapy 2007;27(7):988-994.
7. Vanek T, Jares M, Fajt R, et al. Fibrinolytic inhibitors in off-pump coronary surgery: A prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). Eur J Cardiothorac Surg 2005;28:563-568.
8. Kincaid EH, Ashburn DA, Hoyle JR, et al. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg 2005;80:1388-1393.
9. Coleman CI, Rigali VT, Hammond J, et al. Evaluating the safety implications of aprotinin use: The Retrospective Evaluation of Aprotinin in CardioThoracic Surgery (REACTS). J Thorac Cardiovasc Surg 2007;133:1547-1552.
10. Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004;128:442-448.
11. Serna DL, Thourani VH, Puskas JD. Antifibrinolytic agents in cardiac surgery: Current controversies. Semin Thorac Cardiovasc Surg 2005;17:52-58.
12. Mangano DT, Tudor JC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354(4):353-356.
13. Karkouti K, Beattie WS, Dattilo KM, et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion- risk cardiac surgery. Transfusion 2006;46:327-338.
14. Hiatt WR. Observational studies of drug safety: Aprotinin and the absence of transparency (Editorial). N Engl J Med 2006;355(21):2171-2173.
15. Ferguson TB. Aprotinin: Are there lessons learned? (Editorial). JAMA 2007;297(5):527-529.
16. Mangano DT, Miao Y, Vuylsteke A. et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007;297(5):471-479.
17. Safety trials in Trasylol's future, but design could prove challenging. The Pink Sheet, September 17, 2007, pp. 8-9.
18. Early communication about an ongoing safety review aprotinin injection. Available at: www.fda.gov/cder/drug/early_comm/aprotinin.htm. Accessed November 31, 2007.
19. Bloom M. Aprotinin (Trasylol) marketing halted over suspected mortality risk. Available at: www.medpagetoday.com/Surgery/GeneralSurgery/dh/7239. Accessed November 6, 2007.
20. Van der Linden PJ, Hardy JF, Trenchant A, De Hert SG. Cardiac surgery with cardiopulmonary bypass: Does aprotinin affect outcome? Br J Anaesth 2007;99(5):646-652.
21. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied Regression Analysis and Multivariable Methods, 3rd ed. Pacific Grove, CA: Duxbury Press, 1998.